Status:

UNKNOWN

Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Urothelial Carcinoma

Eligibility:

All Genders

Brief Summary

1. To investigate the relationship between arsenic methylation enzymes (AS3MT, PNP,GSTO1, and GSTO2) genetic polymorphism and UC risk. 2. To explore the relationship between cigarettes metabolites (NN...

Detailed Description

Urothelial carcinoma (UC) arises exclusively from the urothelium including the renal pelvis,ureter, bladder and urethra, with bladder transitional cell carcinoma (TCC) being the most common form. Arse...

Eligibility Criteria

Inclusion

  • project recruited 420 UC patients in Taiwan University Hospital

Exclusion

  • \-

Key Trial Info

Start Date :

August 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

420 Patients enrolled

Trial Details

Trial ID

NCT00854464

Start Date

August 1 2008

Last Update

March 3 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Urology/National Taiwan University Hospital

Taipei, Taiwan, 10002